Secondary Logo

Journal Logo

June 1994 - Volume 15 - Issue 6
pp: 403-496

PDF Only



PDF Only


Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases

SCHATTEN, C.; BARRADA, M.; MANDEVILLE, R.; More

Nuclear Medicine Communications. 15(6):422-429-429, June 1994.


PDF Only



PDF Only



PDF Only